Retraction Note: MiR-338-5p ameliorates pathological cardiac hypertrophy by targeting CAMKIIδ

IF 7.5 3区医学 Q1 CHEMISTRY, MEDICINAL Archives of Pharmacal Research Pub Date : 2025-01-02 DOI:10.1007/s12272-024-01530-0

Kailong Li, Yuedong Lin, Cong Li

引用次数: 0

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

注：MiR-338-5p通过靶向CAMKIIδ改善病理性心肌肥厚。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Archives of Pharmacal Research 医学-药学

CiteScore

13.40

自引率

9.00%

发文量

审稿时长

3.3 months

期刊介绍： Archives of Pharmacal Research is the official journal of the Pharmaceutical Society of Korea and has been published since 1976. Archives of Pharmacal Research is an interdisciplinary journal devoted to the publication of original scientific research papers and reviews in the fields of drug discovery, drug development, and drug actions with a view to providing fundamental and novel information on drugs and drug candidates.

期刊最新文献

Bispecific antibody-drug conjugates: a modular blueprint for next-generation cancer therapeutics. Discovery of a potent STAT3 inhibitor WR-S-647 for the treatment of ADPKD. PF protects retinal pigment epithelial cells from oxidative injury by enhancing mitophagy through a CUL3-dependent AMPK/ULK1 pathway. Ischemic stroke neuroprotection revisited: translational barriers and a phase-resolved, biomarker-anchored framework. cis-Clerodane-type diterpenoids from Tinospora crispa and their anticancer potential.